Vaccinations

Rafael de la Cámara

doi:10.1007/978-3-030-02278-5_29

Vaccinations

Review

In: The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 29.

Author

Rafael de la Cámara¹

Book Editors

Enric Carreras¹, Carlo Dufour², Mohamad Mohty³, Nicolaus Kröger⁴

Affiliation

¹ Department of Hematology, Hospital de la Princesa, Madrid, Spain

Book Affiliations

¹ Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Catalunya, Barcelona, Spain
² Hematology Unit, IRCCS Giannina Gaslini, Geneva, Switzerland
³ Department of Hematology, Pierre and Marie Curie University, Paris, France
⁴ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppend, Hamburg, Germany

PMID: 32091793
Bookshelf ID: NBK553979
DOI: 10.1007/978-3-030-02278-5_29

Excerpt

Vaccination should be considered a routine practice for all HSCT receptors, either autologous or allogeneic, adults or children. It should be implemented in all HSCT programs.

Sections

29.1. General Concepts
29.2. General Principles of Vaccination in HSCT Patients
29.3. Benefits and Risks of Vaccination in HSCT Patients
29.4. Vaccination Recommendations
29.5. Specific Vaccines
29.6. Vaccinations Before Travel to Areas Endemic for Infections (See Table 29.3) (Ljungman et al. 2009)
29.7. Serological Testing
29.8. Vaccinations for Donors, Close Contacts/Family, and HCWs of HSCT Recipients (See Table 29.4) (Ljungman et al. ; Cordonnier et al. ; Rubin et al. 2014)
References

Publication types

Review